Method of preventing or reducing platelet loss during extracorporeal circulation using a thromboxane A.sub.2 receptor antagonist
US4820733A · kind A · utility
0Cited by
0References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 7, 1988 |
| Grant date | Apr 11, 1989 |
| Priority date | — |
| Expiry date | Mar 7, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for preventing or reducing platelet loss during extracorporeal circulation, such as during coronary artery bypass or graft surgery by administering a thromboxane A.sub.2 antagonist alone or with prostacyclin and/or a prostacyclin mimic.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.